Docosahexaenoic acid inhibition of inflammation is partially via cross-talk between Nrf2/heme oxygenase 1 and IKK/NF-κB pathways

Journal of Nutritional Biochemistry

Volumn 24, Issue 1, 2013, Pages 204-212

  Yang, Ya Chen ^a   Lii, Chong Kuei ^b   Wei, Yu Ling ^b   Li, Chien Chun ^c   Lu, Chia Yang ^c   Liu, Kai Li ^c   Chen, Haw Wen ^b  

^a ASIA UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Docosahexaenoic acid (DHA); Heme oxygenase 1 (HO 1); Intercellular adhesion molecule 1 (ICAM 1); Nuclear factor erythroid 2 related factor 2 (Nrf2); Tumor necrosis factor alpha (TNF )

Indexed keywords

DNA BINDING PROTEIN; DOCOSAHEXAENOIC ACID; HEME OXYGENASE 1; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEASOME; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT RESPONSIVE ELEMENT; ARTICLE; ATTENUATION; CELL ADHESION; CELL LINE; CELL NUCLEUS; CELL VIABILITY; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; LIPID PEROXIDATION; MEDIATOR; OXIDATIVE STRESS; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REPORTER GENE; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL ADHESION; CELL LINE; DOCOSAHEXAENOIC ACIDS; ENDOTHELIUM, VASCULAR; GENE KNOCKDOWN TECHNIQUES; HEME OXYGENASE-1; HL-60 CELLS; HUMANS; I-KAPPA B KINASE; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; NF-E2-RELATED FACTOR 2; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84870445676     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.05.003     Document Type: Article

References (48)

1. Blake G.J., Ridker P.M. Novel clinical markers of vascular wall inflammation. Circ Res 2001, 89:763-771.
2. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
3. Oh J.H., Park E.J., Park J.W., Lee J., Lee S.H., Kwon T.K. A novel cyclin-dependent kinase inhibitor down-regulates tumor necrosis factor-alpha (TNF-alpha)-induced expression of cell adhesion molecules by inhibition of NF-kappaB activation in human pulmonary epithelial cells. Int Immunopharmacol 2010, 10:572-579.
4. Karin M., Delhase M. The I kappa B kinase (IKK) and NF-kappa B: key elements of proinflammatory signalling. Semin Immunol 2000, 12:85-98.
5. Farombi E.O., Surh Y.J. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection. J Biochem Mol Biol 2006, 39:479-491.
6. Idriss N.K., Blann A.D., Lip G.Y. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol 2008, 52:971-978.
7. Paine A., Eiz-Vesper B., Blasczyk R., Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol 2010, 80:1895-1903.
8. Ishikawa K., Sugawara D., Goto J., Watanabe Y., Kawamura K., Shiomi M., et al. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 2001, 104:1831-1836.
9. Ishikawa K., Sugawara D., Wang X., Suzuki K., Itabe H., Maruyama Y., et al. Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circ Res 2001, 88:506-512.
10. Yet S.F., Layne M.D., Liu X., Chen Y.H., Ith B., Sibinga N.E., et al. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 2003, 17:1759-1761.
11. Alam J., Cook J.L. Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway. Curr Pharm Des 2003, 9:2499-2511.
12. Kaspar J.W., Niture S.K., Jaiswal A.K. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med 2009, 47:1304-1309.
13. Mullen A., Loscher C.E., Roche H.M. Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages. J Nutr Biochem 2010, 21:444-450.
14. Simopoulos A.P. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 2002, 21:495-505.
15. Ghosh-Choudhury T., Mandal C.C., Woodruff K., St Clair P., Fernandes G., Choudhury G.G., et al. Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth. Breast Cancer Res Treat 2009, 118:213-228.
16. Paulo M.C., Andrade A.M., Andrade M.L., Morais M.G., Kiely M., Parra D., et al. Influence of n-3 polyunsaturated fatty acids on soluble cellular adhesion molecules as biomarkers of cardiovascular risk in young healthy subjects. Nutr Metab Cardiovasc Dis 2008, 18:664-670.
17. Brown A.A., Hu F.B. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 2001, 73:673-686.
18. Chen H., Li D., Chen J., Roberts G.J., Saldeen T., Mehta J.L. EPA and DHA attenuate ox-LDL-induced expression of adhesion molecules in human coronary artery endothelial cells via protein kinase B pathway. J Mol Cell Cardiol 2003, 35:769-775.
19. Mayer K., Merfels M., Muhly-Reinholz M., Gokorsch S., Rosseau S., Lohmeyer J., et al. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am J Physiol Heart Circ Physiol 2002, 283:H811-H818.
20. von Schacky C. n-3 PUFA in CVD: influence of cytokine polymorphism. Proc Nutr Soc 2007, 66:166-170.
21. Spector A.A. Structure and lipid binding properties of serum albumin. Methods Enzymol 1986, 128:320-329.
22. Liao B.C., Hsieh C.W., Liu Y.C., Tzeng T.T., Sun Y.W., Wung B.S. Cinnamaldehyde inhibits the tumor necrosis factor-alpha-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-kappaB activation: effects upon IkappaB and Nrf2. Toxicol Appl Pharmacol 2008, 229:161-171.
23. Yu A.L., Lu C.Y., Wang T.S., Tsai C.W., Liu K.L., Cheng Y.P., et al. Induction of heme oxygenase 1 and inhibition of tumor necrosis factor alpha-induced intercellular adhesion molecule expression by andrographolide in EA.hy926 cells. J Agric Food Chem 2010, 58:7641-7648.
24. Cheng W.L., Lii C.K., Chen H.W., Lin T.H., Liu K.L. Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-kappaB pathway. J Agric Food Chem 2004, 52:71-78.
25. van de Stolpe A., Caldenhoven E., Stade B.G., Koenderman L., Raaijmakers J.A., Johnson J.P., et al. 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J Biol Chem 1994, 269:6185-6192.
26. Stangl V., Lorenz M., Meiners S., Ludwig A., Bartsch C., Moobed M., et al. Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin-proteasome pathway. FASEB J 2004, 18:272-279.
27. Woo C.H., Eom Y.W., Yoo M.H., You H.J., Han H.J., Song W.K., et al. Tumor necrosis factor-alpha generates reactive oxygen species via a cytosolic phospholipase A2-linked cascade. J Biol Chem 2000, 275:32357-32362.
28. Kisselev A.F., Goldberg A.L. Proteasome inhibitors: from research tools to drug candidates. Chem Biol 2001, 8:739-758.
29. Abraham N.G., Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 2005, 39:1-25.
30. Pae H.O., Lee Y.C., Chung H.T. Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. Recent Pat Inflamm Allergy Drug Discov 2008, 2:159-165.
31. Kobayashi A., Kang M.I., Watai Y., Tong K.I., Shibata T., Uchida K., et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol Cell Biol 2006, 26:221-229.
32. Aires V., Hichami A., Filomenko R., Plé A., Rébé C., Bettaieb A., et al. Docosahexaenoic acid induces increases in [Ca2+]i via inositol 1,4,5-triphosphate production and activates protein kinase C gamma and -delta via phosphatidylserine binding site: implication in apoptosis in U937 cells. Mol Pharmacol 2007, 72:1545-1556.
33. Lu D.Y., Tsao Y.Y., Leung Y.M., Su K.P. Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for ω-3 fatty acids. Neuropsychopharmacology 2010, 35:2238-2248.
34. Lu C.Y., Li C.C., Lii C.K., Yao H.T., Liu K.L., Tsai C.W., et al. Andrographolide-induced pi class of glutathione S-transferase gene expression via PI3K/Akt pathway in rat primary hepatocytes. Food Chem Toxicol 2011, 49:281-289.
35. Chang H.C., Chen H.W., Tung H.S., Liu K.L., Tsai C.W., Lii C.K. Butein up-regulates the expression of the pi class of glutathione S-transferase in rat primary hepatocytes through the ERK/AP-1 pathway. J Agric Food Chem 2010, 58:8994-9000.
36. Chen W., Esselman W.J., Jump D.B., Busik J.V. Anti-inflammatory effect of docosahexaenoic acid on cytokine-induced adhesion molecule expression in human retinal vascular endothelial cells. Invest Ophthalmol Vis Sci 2005, 46:4342-4347.
37. Casos K., Saiz M.P., Ruiz-Sanz J.I., Mitjavila M.T. Atherosclerosis prevention by a fish oil-rich diet in apoE(-/-) mice is associated with a reduction of endothelial adhesion molecules. Atherosclerosis 2008, 201:306-317.
38. Bourdillon M.C., Poston R.N., Covacho C., Chignier E., Bricca G., McGregor J.L. ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE(-/-)/ICAM-1(-/-)) fed a fat or a chow diet. Arterioscler Thromb Vasc Biol 2000, 20:2630-2635.
39. Lopez-Franco O., Hernandez-Vargas P., Ortiz-Munoz G., Sanjuan G., Suzuki Y., Ortega L., et al. Parthenolide modulates the NF-kappaB-mediated inflammatory responses in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26:1864-1870.
40. Denk A., Goebeler M., Schmid S., Berberich I., Ritz O., Lindemann D., et al. Activation of NF-kappa B via the Ikappa B kinase complex is both essential and sufficient for proinflammatory gene expression in primary endothelial cells. J Biol Chem 2001, 276:28451-28458.
41. Kaileh M., Vanden Berghe W., Heyerick A., Horion J., Piette J., Libert C., et al. Withaferin A strongly elicits IkappaB kinase beta hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem 2007, 282:4253-4264.
42. Takahashi T., Morita K., Akagi R., Sassa S. Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr Med Chem 2004, 11:1545-1561.
43. Soares M.P., Seldon M.P., Gregoire I.P., Vassilevskaia T., Berberat P.O., Yu J., et al. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 2004, 172:3553-3563.
44. Li W., Khor T.O., Xu C., Shen G., Jeong W.S., Yu S., et al. Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem Pharmacol 2008, 76:1485-1489.
45. Gong P., Hu B., Cederbaum A.I. Diallyl sulfide induces heme oxygenase-1 through MAPK pathway. Arch Biochem Biophys 2004, 432:252-260.
46. Numazawa S., Ishikawa M., Yoshida A., Tanaka S., Yoshida T. Atypical protein kinase C mediates activation of NF-E2-related factor 2 in response to oxidative stress. Am J Physiol Cell Physiol 2003, 285:C334-C342.
47. Hwang Y.P., Jeong H.G. Mechanism of phytoestrogen puerarin-mediated cytoprotection following oxidative injury: estrogen receptor-dependent up-regulation of PI3K/Akt and HO-1. Toxicol Appl Pharmacol 2008, 233:371-381.
48. D'Autreaux B., Toledano M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007, 8:813-824.